Average Co-Inventor Count = 9.17
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (42 from 329 patents)
2. Pfizer Corporation (2 from 4,455 patents)
3. Celgene Corporation (2 from 550 patents)
4. Mirati Therapeutics, Inc. (2 from 38 patents)
44 patents:
1. 11964989 - KRas G12D inhibitors
2. 11802127 - 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors
3. 11780835 - Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases
4. 11691973 - 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors
5. 11453683 - KRas G12D inhibitors
6. 11247990 - Bicyclic fused pyridine compounds as inhibitors of TAM kinases
7. 11104676 - Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases
8. 11028093 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
9. 10889589 - Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
10. 10851080 - Methods of treatment using pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds
11. 10835533 - 1 -((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea as a TrkA kinase inhibitor
12. 10758542 - Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors
13. 10730880 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors
14. 10351575 - Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
15. 10323022 - Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors